Our Voices Matter: racial-justice activism program to reduce depression in Black and Latinx youth
Official title: Our Voices Matter: Racial Justice Activism Intervention to Address Structural Racism and Prevent Depression in Black and Latinx Youth
Run by Ann & Robert H Lurie Children's Hospital of Chicago · NCT07216326 · Data updated 2026-11-12
This program tests whether participating in racial-justice activism can reduce depressive symptoms and stress-related physical risk in Black and Latinx youth ages 15-20.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 20 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Ann & Robert H Lurie Children's Hospital of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | June 6, 2025 |
| Main results expected | December 1, 2028 |
| Study ends | December 29, 2028 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07216326 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking Black or Latinx young people aged 15–20 who can attend the in-person half-day sessions in Chicago and are interested in activism or life-skills groups.
✕Probably not a fit
Those who are younger than 15 or older than 20, non–English speakers, unable to attend in-person sessions, do not identify as Black or Latinx, or who require intensive psychiatric care are unlikely to benefit from this community-based intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, group-based behavioral trial will enroll 300 Black and Latinx participants aged 15–20 in Chicago and randomize 150 to a racial-justice activism intervention and 150 to an attention-control life skills program. Each arm includes five half-day in-person interactive sessions followed by virtual small peer groups to continue the activities, with the activism arm focused on grassroots organizing around structural racism and the control arm focused on life-skills training. Outcomes include self-reported depressive symptoms and measures of physiological stress such as allostatic load and metabolic risk indicators, collected at baseline and follow-up timepoints. Randomization is block-stratified to balance race, ethnicity, and gender.
Why it matters
Potential benefit: If successful, the program could lower depressive symptoms and reduce stress-related physiological risks among Black and Latinx adolescents.
How similar studies have gone: This approach is relatively novel for a randomized trial: observational work links youth activism with improved well-being, but randomized evidence testing activism to reduce depressive symptoms and physiological stress is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 15-20 years old 2. Identify as Black and/ or Latinx 3. Speak English Exclusion Criteria: 1. Younger than 15 years old, or older than 20 years old 2. Unable to attend the in-person sessions 3. Non-fluent English speaker 4. Do not identify as Black or Latinx
Where it's running
-
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Elan C Hope, PhD — Policy Research Associates
- Study coordinator: Nia Heard-Garris, MD, MBA, MSc
- Email: nheardgarris@luriechildrens.org
- Phone: 3122272664
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rise & Thrive: a community-engagement program to help youth manage stress and depressive symptoms
A group-based program tests whether community engagement activities can help Black and/or Hispanic/Latine youth aged 15-20 see reductions in depressive symptoms.
-
Understanding health trends in Puerto Rico
This study is trying to understand health trends in Puerto Rico by looking at diet, mental health, and heart health in adults aged 30-75 over time.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Low-Calorie Diet in adolescents with Familial Mediterranean Fever and metabolic syndrome
A group of adolescents with both FMF and metabolic syndrome will try a low-calorie diet for 3 months to see if it helps manage metabolic symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.